Recurrence-specific markers for determining treatment strategies and diagnosing prognosis of patient of clear cell renal cell carcinoma

摘要

The present invention relates to a recurrence diagnosis or prognostic marker for recurrence diagnosis of renal cancer patients, wherein mutation of the gene of the present invention and recurrence of renal cancer are correlated, and mutation of the gene of the present invention and total survival rate of recurrent renal cancer patients Alternatively, since disease-free survival rates are associated with each other, the mutated gene of the present invention can be used as a marker for diagnosing renal cancer recurrence, predicting the difference in therapeutic effect of renal cancer based on recurrence or prognosis of renal cancer patients.